Sex-linked recessive disorders

1. High-Yield Summary

• Hemophilia A and B (Factor VIII and IX Deficiencies): X-linked recessive coagulopathies that cause recurrent intra-articular bleeding (hemarthrosis), driving iron-mediated synovial proliferation, neoangiogenesis, and progressive chondrolysis (Arnold-Hilgartner stages I to V). Knee, elbow, and ankle target joints predominate. Management requires multidisciplinary hematology coordination: perioperative factor correction to 100% peak before major surgery (maintained >50% for 7 to 14 days), routine screening for neutralizing inhibitors (Bethesda assay), and timely intervention with chemical or radioisotope synovectomy before irreversible subchondral destruction occurs.
• Duchenne Muscular Dystrophy (DMD): Caused by out-of-frame mutations in the DMD gene (Xp21.2) resulting in near-total absence of dystrophin, leading to sarcolemmal fragility, myofiber necrosis, fibrofatty muscle replacement, Gowers sign, pseudohypertrophy, equinovarus contractures, and progressive neuromuscular collapsing lordoscoliosis. Posterior spinal fusion (PSF) from T2/T3 to the pelvis is indicated when the Cobb angle reaches 20 to 30 degrees in non-ambulatory patients before forced vital capacity (FVC) drops below 30% to 50% of predicted values.
• Critical Anesthetic Contraindication in DMD/BMD: Succinylcholine and volatile halogenated inhalational anesthetics (e.g., isoflurane, sevoflurane, desflurane) are strictly contraindicated due to the lethal risk of malignant hyperthermia-like rhabdomyolysis, massive hyperkalemic flux, intractable ventricular arrhythmias, and cardiac arrest. Total Intravenous Anesthesia (TIVA) using propofol and narcotics is mandatory.
• Hunter Syndrome (Mucopolysaccharidosis Type II; MPS II): Caused by iduronate-2-sulfatase (IDS) deficiency (Xq28), resulting in progressive lysosomal accumulation of dermatan and heparan sulfate. Manifests as dysostosis multiplex (anteriorly beaked vertebrae, spatulate ribs, proximally pointed metacarpals), severe occult pediatric carpal tunnel syndrome (often manifesting silently as claw hand and loss of fine motor dexterity without sensory complaints), and odontoid hypoplasia predisposing to life-threatening atlantoaxial subluxation and cervicomedullary compression.
• Collateral Sex-Linked Musculoskeletal Entities: Emery-Dreifuss muscular dystrophy (EDMD, emerin/EMD mutation) presents with early elbow flexion and Achilles contractures, rigid spine, humeroperoneal weakness, and lethal cardiac conduction blocks; Lesch-Nyhan syndrome (HPRT1 deficiency) presents with hyperuricemic tophaceous gout, choreoathetosis, dystonia, and severe compulsive self-mutilation requiring orthopaedic bite guards, positioning orthoses, and selective contracture releases.

2. Anatomy

Surgical intervention in patients with sex-linked recessive musculoskeletal disorders requires rigorous navigation of altered soft-tissue planes, fragile osteopenic bone, distorted anatomy, and hypertrophied neurovascular networks.

The Knee in Hemophilic Arthropathy and Arthroplasty

Chronic hemarthroses transform the knee into a hypervascular, contractured joint with dense synovial pannus, severe periarticular fibrosis, and angular deformities (typically fixed flexion combined with external rotation and valgus alignment). Exposure is obtained through a standard anterior midline longitudinal skin incision and a medial parapatellar arthrotomy. In cases of longstanding flexion contracture and patellar entrapment, eversion of the patella is precluded by extensive quadriceps shortening. Extending the exposure via a rectus snip, V-Y quadricepsplasty, or tibial tubercle osteotomy is frequently necessary to avoid avulsing the patellar tendon from an osteopenic tibial tuberosity.

Neurovascular Danger Zone: The popliteal neurovascular bundle adheres intimately to the scarred posterior capsule. Vigorous posterior capsular release or aggressive resection of posterior osteophytes places the popliteal artery and tibial nerve at acute risk. Furthermore, acute intraoperative correction of severe fixed flexion contractures exceeding 20 to 30 degrees stretches the common peroneal nerve as it traverses the fibular neck, leading to traction neuropraxia or permanent motor foot drop.

The Elbow in Hemophilic Synovectomy and Radial Head Resection

The elbow is the second most common target joint in hemophilia, marked by massive radial head enlargement, trochlear notch deepening, and anterior/posterior capsular contracture. Surgical exposure of the radiocapitellar joint is achieved using the lateral Kocher approach, utilizing the internervous plane between the anconeus (innervated by the radial nerve) and the extensor carpi ulnaris (innervated by the posterior interosseous nerve). Deep dissection must remain strictly posterior to the mid-axial line of the radial head.

Neurovascular Danger Zone: The posterior interosseous nerve (PIN) winds around the radial neck within the supinator muscle (arcade of Frohse). Extraperiosteal dissection or unguided retractor placement anterior to the radial neck risks permanent PIN paralysis, with loss of metacarpophalangeal extension and thumb abduction. The ulnar nerve is similarly threatened along the posteromedial elbow during medial synovectomy or posterior capsulotomy, where it is frequently encased in dense fibrous tissue and ectopic bone.

Pelvic and Femoral Anatomy in Hemophilic Pseudotumors

Hemophilic pseudotumors develop predominantly in the pelvis (iliac wing) and proximal femur due to repeated subperiosteal or intramuscular bleeding within the iliopsoas sheath. As the pseudotumor expands, it produces massive bony erosion, cortical scalloping, and displacement of adjacent viscera. Iliopsoas pseudotumors compress the femoral nerve against the iliopectineal fascia and displace the external iliac and femoral vessels anteriorly. Surgical dissection must establish proximal vascular control of the common and external iliac vessels through an extended retroperitoneal approach before mobilizing the fibrous pseudotumor capsule.

The Spine and Pelvic Foundation in Duchenne Muscular Dystrophy

Posterior spinal instrumentation and fusion in DMD requires extensive subperiosteal exposure from the upper thoracic spine (T2 or T3) down to the sacrum and pelvis. In non-ambulatory boys, pelvic fixation is essential to correct pelvic obliquity, restore a level sitting foundation, and prevent painful impingement of the lower ribs against the iliac crests.

Pelvic Landmarks and Danger Zones: Fixation to the pelvis is routinely performed using S2-alar-iliac (S2AI) screws or traditional iliac bolts. The starting point for an S2AI screw is located approximately 1 mm inferior and 1 mm lateral to the S1 dorsal foramen. The trajectory aims 40 degrees laterally in the transverse plane and 35 to 40 degrees caudally in the sagittal plane, crossing the sacroiliac joint into the dense column of bone above the greater sciatic notch. Violating the sciatic notch threatens the superior gluteal artery and sciatic nerve, whereas anterior cortical perforation risks catastrophic internal iliac vessel injury.

The Craniocervical Junction and Carpal Tunnel in Hunter Syndrome

In Hunter syndrome (MPS II), progressive GAG storage produces two distinct high-risk anatomical abnormalities: craniocervical stenosis and carpal tunnel entrapment.

• Craniocervical Junction: Odontoid hypoplasia, aplasia, or os odontoideum creates severe atlantoaxial instability (increased anterior atlantodental interval, AADI > 3.5 mm). Concurrently, marked GAG deposition expands the retro-odontoid soft tissues and thickens the apical ligament, tectorial membrane, and ligamentum flavum, forming a compressive pseudotumor. The space available for the cord (SAC) is critically narrowed, exposing the cervicomedullary junction to compression during physiological cervical flexion and extension. The vertebral arteries traversing the transverse foramina of C1 and the foramen magnum margin represent key structures at risk during surgical decompression and instrumented occipitocervical fusion.
• Volar Wrist and Carpal Tunnel: The transverse carpal ligament (flexor retinaculum) undergoes profound hypertrophic thickening secondary to intracellular GAG deposition, converting the carpal tunnel into a rigid, unyielding compartment. Massive tenosynovial hypertrophy of the flexor digitorum superficialis and profundus tendons further raises intracompartmental pressures. The median nerve becomes flattened and ischemic deep to the distal retinacular margin. The recurrent motor branch of the median nerve, which supplies the thenar muscles (abductor pollicis brevis, opponens pollicis, superficial head of flexor pollicis brevis), is acutely vulnerable during extended retinacular release.

3. Pathogenesis

Sex-linked recessive disorders in musculoskeletal surgery arise from single-gene defects located on the X chromosome. Because males possess only one X chromosome (hemizygous), inheriting a single mutant allele results in full phenotypic manifestation, whereas females are typically unaffected or minimally symptomatic carriers unless extreme lyonization (skewed X-inactivation) occurs.

Hemophilia A (F8) and Hemophilia B (F9): Coagulation Failure to Arthropathy

Hemophilia A results from mutations in the F8 gene (Xq28), leading to Factor VIII deficiency, whereas Hemophilia B (Christmas disease) is caused by mutations in the F9 gene (Xq27.1), leading to Factor IX deficiency. In approximately 45% of patients with severe Hemophilia A, an intron 22 inversion is the causative genetic defect. Both Factor VIII and Factor IX constitute the intrinsic tenase complex on the phospholipid membrane of activated platelets. This complex catalyzes the activation of Factor X to Factor Xa. Deficiency of either factor disables the intrinsic coagulation pathway, impairing the secondary burst of thrombin generation necessary to convert fibrinogen into a stable, cross-linked fibrin clot.

The pathogenesis of hemophilic arthropathy follows a cascade of biological degradation:

• Intra-Articular Hemorrhage: Minor mechanical shearing or microtrauma tears fragile synovial microvessels, producing hemarthrosis. Intact erythrocytes fill the joint space and undergo hemolysis, releasing free hemoglobin and ferric iron into the synovial fluid.
• Synovial Macrophage Phagocytosis and Siderosis: Type A synovial lining cells (macrophages) phagocytose free iron and degrade it into intracellular hemosiderin. Excessive iron saturation overwhelms normal ferritin storage capacity, triggering hydroxyl free radical formation via the iron-catalyzed Fenton reaction (Fe2+ + H2O2 -> Fe3+ + OH* + OH-).
• Synovial Proliferation and Neoangiogenesis: Intracellular reactive oxygen species (ROS) activate the nuclear factor-kappa B (NF-kappa-B) pathway and proto-oncogenes such as c-myc. Synoviocytes upregulate inflammatory cytokines, notably tumor necrosis factor-alpha (TNF-alpha), interleukin-1-beta (IL-1-beta), and interleukin-6 (IL-6). Concurrently, tissue hypoxia upregulates hypoxia-inducible factor 1-alpha (HIF-1-alpha) and vascular endothelial growth factor (VEGF), inducing dysregulated synovial neoangiogenesis. The resulting synovium becomes a thick, villous, friable pannus rich in fragile, thin-walled capillary loops that bleed upon minimal motion, establishing a self-perpetuating cycle: bleed -> synovitis -> neoangiogenesis -> rebleed.
• Cartilage Destruction and Chondrocyte Apoptosis: Iron and inflammatory cytokines exert a direct cytotoxic effect on articular cartilage. They inhibit chondrocyte proteoglycan synthesis and stimulate the release of matrix metalloproteinases (MMP-1, MMP-3, MMP-13) and aggrecanases (ADAMTS-4, ADAMTS-5). Chondrocytes undergo apoptotic cell death, leading to matrix fibrillation, full-thickness chondral erosion, subchondral bone exposure, and subchondral cyst (geode) formation from intraosseous synovial fluid extrusion under hydraulic load.
• Hemophilic Pseudotumors: In 1% to 2% of severe hemophiliacs, repeated hematomas occurring within subperiosteal bone or unyielding fascial envelopes fail to resorb. Progressive encapsulation by dense fibrous tissue creates an encapsulated mass that expands due to recurrent internal microbleeds and osmotic fluid shifts. The chronic internal hydrostatic pressure induces progressive pressure osteolysis of adjacent bone cortices, extensive soft-tissue necrosis, and neurovascular entrapment.

Duchenne and Becker Muscular Dystrophy: Dystrophin Deficiency and Sarcolemmal Collapse

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders arising from mutations in the DMD gene located at Xp21.2, which spans 2.4 megabases and comprises 79 exons. The DMD gene encodes dystrophin, a 427 kDa rod-shaped structural cytoskeletal protein located on the inner surface of the sarcolemma in skeletal and cardiac muscle.

The reading frame hypothesis dictates the clinical phenotype: out-of-frame deletions, duplications, or nonsense mutations disrupt the translational reading frame, leading to premature stop codons and near-complete absence of functional dystrophin (<1% to 3% of normal levels) in DMD. Conversely, in-frame mutations preserve the downstream reading frame, generating a truncated but partially functional dystrophin protein (20% to 50% of normal quantity), causing the milder BMD phenotype.

The molecular cascade driving muscle degeneration and spinal deformity comprises:

• Dystrophin-Glycoprotein Complex (DGC) Dissociation: Dystrophin serves as an anchor connecting intracellular filamentous actin (F-actin) to the extracellular matrix protein laminin-211 via the transmembrane DGC (composed of alpha/beta-dystroglycan, sarcoglycans, dystrobrevin, and syntrophins). In the absence of dystrophin, the entire DGC fails to assemble stably at the sarcolemma, rendering the muscle membrane fragile.
• Mechanical Membrane Tears and Calcium Overload: Physiological mechanical strain during eccentric muscle contraction produces microtears across the unsupported sarcolemma. Extracellular calcium floods into the sarcoplasm through tears and stretch-activated calcium channels (TRPC channels). Elevated intracellular calcium activates calcium-dependent neutral proteases (calpains), which degrade myofibrillar proteins, trigger mitochondrial calcium overload, induce reactive oxygen species generation, and precipitate necrosis of the myofiber.
• Exhaustion of Satellite Cells and Fibrofatty Replacement: Initial cycles of muscle fiber necrosis trigger regenerative attempts by resident muscle stem cells (satellite cells). However, repetitive necrosis rapidly depletes satellite cell regenerative reserves. Muscle fibers are progressively replaced by collagenous connective tissue and dense adipocytes, producing pseudohypertrophy in the gastrocnemius, soleus, and deltoid muscles.
• Biomechanical Collapse into Spinal Deformity: Selective and progressive muscle weakness causes muscle imbalances across joints. Weakness of the quadriceps and gluteus maximus leads to compensatory hyperlordosis and hip flexor contractures. As asymmetric weakness involves the paraspinal musculature and trunk stabilizers, the spine loses muscular balance. Once the patient becomes wheelchair-bound, axial gravitational loading causes progressive, collapsing neuromuscular lordoscoliosis, pelvic obliquity, and restrictive pulmonary compromise.

Hunter Syndrome (MPS II): Lysosomal GAG Accumulation and Dysostosis Multiplex

Hunter syndrome (Mucopolysaccharidosis Type II; MPS II) is caused by mutations in the IDS gene (Xq28), which encodes the lysosomal enzyme iduronate-2-sulfatase. This enzyme is required for the sequential degradation of two major glycosaminoglycans (GAGs): dermatan sulfate and heparan sulfate. Loss of enzyme activity leads to progressive, unmitigated storage of undegraded GAGs within lysosomes across multiple cell lines, including articular chondrocytes, osteoblasts, fibroblasts, and vascular endothelial cells.

Intracellular GAG accumulation initiates a chronic inflammatory reaction through activation of Toll-like receptor 4 (TLR4), triggering downstream release of TNF-alpha, nitric oxide, and metalloproteinases. In growing bones, chondrocyte storage disrupts the normal columnar architecture of the physis, leading to abnormal endochondral ossification, delayed secondary ossification centers, epiphyseal dysgenesis, and defective periosteal bone remodeling. This systemic skeletal dysplasia is designated dysostosis multiplex. Concurrently, GAG deposition within fibrous tissues thickens ligaments, dura mater, and flexor retinacula, producing compressive neuropathies and myelopathies.

Collateral Sex-Linked Disorders: EDMD and Lesch-Nyhan Syndrome

• Emery-Dreifuss Muscular Dystrophy (X-linked EDMD): Caused by mutations in the EMD gene (Xq28), encoding emerin, an inner nuclear membrane protein that anchors the nuclear lamina (lamin A/C) and regulates nuclear mechanotransduction and chromatin architecture. Emerin deficiency disrupts nuclear envelope integrity, leaving muscle nuclei vulnerable to mechanical rupture during contraction. This induces a characteristic triad: early joint contractures (elbow flexors, Achilles tendon, posterior cervical spine), slowly progressive humeroperoneal muscle weakness, and cardiac conduction defects (atrioventricular block, atrial paralysis, dilated cardiomyopathy) that can lead to sudden death.
• Lesch-Nyhan Syndrome: Caused by mutations in the HPRT1 gene (Xq26.2-q26.3), encoding hypoxanthine-guanine phosphoribosyltransferase. HPRT1 is the key enzyme of the purine salvage pathway, converting hypoxanthine to inosine monophosphate (IMP) and guanine to guanosine monophosphate (GMP). Its absence accelerates de novo purine synthesis, leading to massive overproduction of uric acid. Musculoskeletal manifestations include severe gouty arthritis, tophaceous joint destruction, choreoathetosis, dystonia, and severe self-injurious biting behaviors causing traumatic digital and perioral amputations.

4. Natural History

Understanding the untreated natural trajectory of these conditions is critical to establish the timing of orthopaedic interventions, evaluate functional prognosis, and avoid preventable morbidity.

Epidemiology

• Hemophilia A: Approximately 1 in 5,000 live male births. Accounts for 80% to 85% of all hemophilia cases. Approximately one-third of cases arise from spontaneous de novo mutations without a family history.
• Hemophilia B: Approximately 1 in 20,000 to 1 in 30,000 live male births. Clinical phenotypes are virtually indistinguishable from Hemophilia A for a given baseline factor activity level.
• Duchenne Muscular Dystrophy: Approximately 1 in 3,500 to 1 in 5,000 live male births, representing the most common inherited lethal myopathy of childhood. One-third of cases represent spontaneous mutations.
• Becker Muscular Dystrophy: Approximately 1 in 18,000 to 1 in 30,000 live male births, with a milder, more heterogeneous progression.
• Hunter Syndrome (MPS II): Approximately 1 in 100,000 to 1 in 170,000 live male births. Severe (early-onset cognitive decline) and attenuated phenotypes exist.

Untreated Disease Trajectory and Prognosis

In Hemophilia, bleeding manifestations typically begin when the child starts crawling or walking (ages 9 to 18 months). In severe disease (factor level <1%), spontaneous hemarthroses occur at an average frequency of 20 to 30 episodes per year if untreated. Repeated hemorrhages establish persistent synovitis within specific target joints (knee > elbow > ankle > shoulder). By the second to third decade of life, untreated patients advance to end-stage Arnold-Hilgartner stage V arthropathy, characterized by complete joint space collapse, severe fibrous ankylosis, and angular contractures. Growth plate hyperemia during skeletal development causes epiphyseal overgrowth, leg-length discrepancies, and early physeal arrest. Hemophilic pseudotumors expand inexorably, ultimately causing pathological fractures, cutaneous fistulization, secondary sepsis, or fatal hemorrhage.

In Duchenne Muscular Dystrophy, boys appear developmentally normal at birth. Mild motor delays become apparent between ages 2 and 4 years, presenting with a waddling gait, frequent falls, and difficulty running. Gowers sign is typically positive by age 5. Progressive proximal muscle weakness forces the child to adopt compensatory hyperlordosis and toe-walking to keep the center of gravity posterior to the hip joint and anterior to the knee joint. Untreated boys lose independent ambulation between ages 8 and 12 years (median 9.5 years). Following wheelchair confinement, the stabilizing effect of ambulatory weight-bearing is lost, precipitating rapid progression of neuromuscular scoliosis at rates exceeding 10 to 20 degrees per year. Progressive thoracic collapsing deformity restricts diaphragmatic and chest wall excursion, resulting in a relentless decline in Forced Vital Capacity (FVC) of 8% to 10% annually. Untreated boys historically succumbed to respiratory failure or dilated cardiomyopathy in their late teens. With modern corticosteroid therapy, non-invasive ventilation (BiPAP), early spinal fusion, and cardioprotective pharmacotherapy, life expectancy has extended into the third and fourth decades.

In Becker Muscular Dystrophy, symptom onset occurs later, typically between ages 5 and 15 years, with loss of ambulation preserved past age 16 and often well into middle adulthood. Importantly, cardiac involvement in BMD does not correlate directly with skeletal muscle weakness; severe dilated cardiomyopathy can develop in fully ambulatory patients and represents the primary cause of mortality.

In Hunter Syndrome, infants appear normal at birth. Between ages 2 and 4 years, progressive somatic manifestations emerge, including coarse facial features, macrocephaly, short stature, stiff joints, claw hands, and hepatosplenomegaly. Chronic GAG deposition within the transverse carpal ligament produces severe, silent median nerve entrapment before age 5; without timely release, irreversible thenar atrophy and loss of thumb opposition ensue. Odontoid hypoplasia combined with retro-odontoid GAG pannus narrows the upper cervical spinal canal, predisposing to progressive spastic tetraparesis and sudden death from acute cervicomedullary compression. Untreated patients with the severe phenotype typically die from cardiopulmonary failure or neurological compromise in their second decade, whereas attenuated individuals may survive into adulthood with preserved cognition but crippling orthopaedic deformities.

5. Clinical Presentation

History

A structured, disorder-specific history is essential to elucidate early functional decline and guide perioperative planning:

• Hemophilia: Inquire about family history in maternal uncles or male cousins, prolonged bleeding following neonatal circumcision, umbilical stump oozing, or extensive intramuscular hematomas following routine childhood immunizations. In older patients, identify specific target joints, frequency of bleeds, and the presence of an early “aura” (a prodromal sensation of intra-articular warmth, tingling, or fullness preceding pain and swelling). Quantify lifetime factor concentrate exposure, previous inhibitor history (peak and current Bethesda titers), and screening status for blood-borne viral pathogens (HIV, Hepatitis B, and Hepatitis C).
• DMD / BMD: Document precise motor milestones: age at independent walking, emergence of toe-walking, frequency of tripping, and difficulty ascending stairs. Note the age at loss of independent ambulation, changes in wheelchair sitting posture, and lateral trunk collapse. Elicit cardiopulmonary symptoms: morning headaches, daytime somnolence, orthopnea, nighttime awakenings (signs of nocturnal hypoventilation), and exertional fatigue. Review the corticosteroid regimen (prednisone or deflazacort dose, duration, and adherence).
• Hunter Syndrome: Obtain a detailed history of recurrent otitis media, chronic rhinorrhea, snoring, obstructive sleep apnea, and previous inguinal or umbilical hernia repairs. Inquire about fine motor skills: dropping eating utensils, inability to button clothing, and progressive finger curling. Critical Historical Pitfall: Young children with MPS II rarely complain of numbness or paresthesias; severe carpal tunnel syndrome presents silently as painless loss of dexterity and progressive hand weakness. Screen for upper motor neuron symptoms: deteriorating gait, frequent tripping, loss of bladder control, and neck discomfort.

Physical Exam

Examination of patients with sex-linked musculoskeletal disorders requires validated provocative maneuvers and quantitative clinical tests:

• Gowers Sign: The patient is positioned supine or seated on the floor and instructed to stand up without external furniture support. -> Positive Finding: Inability to rise directly; the patient rolls prone, assumes a four-point stance, and uses the hands to sequentially “climb up” the shins, knees, and thighs to attain an upright posture, compensating for severe gluteus maximus and quadriceps femoris weakness [Sensitivity ~95%, Specificity ~85% in young boys with DMD].
• Meryon Sign (Shoulder Slipping Maneuver): The examiner places hands under the patient’s axillae and attempts to lift the child vertically. -> Positive Finding: The child slips through the examiner’s hands without elevating the torso, caused by marked weakness and atrophy of the periscapular stabilizers, particularly the serratus anterior, latissimus dorsi, and pectoralis major [Sensitivity ~88%, Specificity ~90%].
• Pseudohypertrophy Inspection and Palpation: Palpation of the gastrocnemius, soleus, infraspinatus, and deltoid muscle bellies. -> Positive Finding: Bulky, visibly enlarged muscle contours that feel abnormally firm, rubbery, and doughy on palpation, reflecting extensive endomysial fibrosis and adipocyte infiltration rather than true muscle fiber hypertrophy.
• Silverskiold Test (for Equinus Deformity): Passive ankle dorsiflexion is measured with the knee held in full extension (0 degrees) and repeated with the knee flexed to 90 degrees, maintaining the subtalar joint in neutral/inversion to lock the transverse tarsal joints. -> Positive Finding: Ankle dorsiflexion limited to 10 degrees) with knee flexion indicates isolated gastrocnemius contracture; persistent dorsiflexion limitation in both positions confirms contracture of the gastrocnemius-soleus complex and Achilles tendon.
• Ober Test (for Iliotibial Band / Tensor Fasciae Latae Contracture): The patient is positioned in lateral decubitus with the pelvis stabilized perpendicular to the table. The affected hip is abducted, extended past the coronal plane to clear the femoral head over the greater trochanter, and then allowed to adduct toward the table under gravity. -> Positive Finding: The thigh remains abducted above the horizontal plane, indicating a fixed iliotibial band and tensor fasciae latae contracture, which contributes to the wide-based, hyperlordotic gait in DMD.
• Thomas Test (for Hip Flexion Contracture): The patient lies supine while the contralateral hip is maximally flexed to the chest to eliminate compensatory lumbar lordosis. -> Positive Finding: The ipsilateral extended thigh lifts off the examination table; the angle between the table and the femur quantifies the fixed hip flexion contracture.
• Durkan Carpal Compression Test in Hunter Syndrome: The examiner applies direct, constant bilateral thumb pressure over the median nerve at the proximal edge of the transverse carpal ligament for 30 seconds. -> Positive Finding: Provocation of pain, numbness, tingling, or withdrawal behavior in the median nerve distribution [Sensitivity ~87%, Specificity ~90%]. Concurrently inspect for flattening of the thenar eminence (abductor pollicis brevis atrophy) and loss of active thumb palmar abduction.
• Hoffman Reflex and Sustained Clonus (for Cervical Myelopathy in MPS II): The middle phalanx of the patient’s middle finger is stabilized while the terminal phalanx is rapidly flicked into flexion. Rapid ankle dorsiflexion is tested for clonus. -> Positive Finding: Involuntary flexion and adduction of the ipsilateral thumb and index finger (positive Hoffman) or >3 beats of sustained rhythmic ankle clonus indicates upper motor neuron compression at the craniocervical junction.
• Hemophilic Joint Assessment (Target Joint Evaluation): Inspection and palpation of knee, elbow, and ankle joints for warmth, tense effusion, and synovial thickness. -> Positive Finding: An acute hemarthrosis manifests as a warm, tense, exquisitely painful, and tender joint held in antalgic flexion; chronic hemophilic synovitis presents as a painless, boggy, spongy synovial swelling with loss of normal bony contours and restricted terminal range of motion.

6. Imaging and Diagnostic Studies

Diagnostic evaluation across sex-linked musculoskeletal disorders combines standardized radiographic surveys, cross-sectional advanced imaging, neurophysiological testing, and confirmatory molecular genetics.

Hemophilia Imaging and Diagnostic Workup

• Plain Radiography: The baseline imaging modality for hemophilic arthropathy. Radiographic hallmarks include periarticular osteopenia, epiphyseal ballooning/overgrowth from chronic hyperemia, squaring of the inferior pole of the patella, widening of the intercondylar notch of the distal femur, deepening of the trochlear notch of the ulna, radial head enlargement, and subchondral geode formation. Plain films are graded using the Arnold-Hilgartner classification.
• Magnetic Resonance Imaging (MRI): The gold standard for detecting pre-radiographic hemophilic arthropathy. Synovial pannus demonstrates low-to-intermediate signal intensity on T1-weighted images and low signal on T2-weighted images. T2* gradient-echo (GRE) sequences exhibit profound “blooming artifact” (signal drop-out) secondary to magnetic susceptibility effects from massive hemosiderin deposits. MRI accurately quantifies chondral loss, subchondral cyst architecture, and occult subperiosteal hematomas.
• Point-of-Care Ultrasonography (HEAD-US Protocol): The Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol provides rapid, non-invasive bedside assessment of target joints. It distinguishes acute hypoechoic intra-articular hemarthrosis from chronic, hyperechoic synovial hypertrophy and evaluates chondral surface integrity without sedation or radiation.
• Coagulation and Inhibitor Assays: Activated partial thromboplastin time (aPTT) is markedly prolonged, whereas prothrombin time (PT/INR) and platelet count are normal. Specific one-stage clotting factor activity assays confirm Factor VIII or IX deficiency. Bethesda Assay: Quantifies neutralizing alloantibody inhibitors against Factor VIII or IX. One Bethesda Unit (BU) is defined as the amount of inhibitor that neutralizes 50% of factor activity in normal plasma after a 2-hour incubation at 37 degrees Celsius. Titer levels are stratified into low-responder (<5 BU) and high-responder (>=5 BU).

Duchenne and Becker Muscular Dystrophy Diagnostic Workup

• Serum Creatine Kinase (CK): Extremely elevated in DMD, typically 10,000 to 50,000 U/L (50 to 100 times the upper reference limit) from birth through early childhood, reflecting continuous sarcolemmal leakage. In late-stage disease, CK levels decline paradoxically due to near-complete loss of viable muscle mass. In BMD, CK levels are moderately elevated (5 to 20 times normal).
• Genetic Testing: Multiplex Ligation-dependent Probe Amplification (MLPA) is the primary diagnostic test, identifying large exonic deletions and duplications in the DMD gene (accounting for ~70% to 75% of mutations). If MLPA is negative, next-generation sequencing (NGS) of all 79 exons identifies point mutations, small indels, and splice-site mutations (~25% to 30%).
• Spine Radiographs: Full-length upright or supported sitting anteroposterior (AP) and lateral spine radiographs (C7 to sacrum/pelvis). Standard measurements include:
  • Cobb Angle: Angle measured between the superior endplate of the cranial-most tilted vertebra and the inferior endplate of the caudal-most tilted vertebra.
  • Pelvic Obliquity Angle: Angle subtended by a line tangent to the highest points of both iliac crests relative to a horizontal reference line or perpendicular to the sacral sacrum. Pelvic obliquity >5 to 10 degrees causes seated instability and unilateral ischial decubitus pressure.
  • Sagittal Thoracic Kyphosis and Lumbar Lordosis: Evaluated on the lateral projection to detect thoracic hypokyphosis or progressive hyperlordosis.
• Pulmonary and Cardiac Function Tests: Preoperative evaluation requires formal spirometry measuring Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), and Peak Cough Flow (PCF). Sitting and supine FVC comparisons detect diaphragmatic weakness (a drop >20% from sitting to supine confirms diaphragmatic paralysis). Transthoracic echocardiography and cardiac MRI quantify left ventricular ejection fraction (LVEF), fractional shortening, and late gadolinium enhancement (identifying subepicardial fibrosis).

Hunter Syndrome (MPS II) Diagnostic Workup

• Biochemical and Molecular Confirmation: Quantitative urinary GAG analysis demonstrates marked excretion of dermatan sulfate and heparan sulfate. Measurement of iduronate-2-sulfatase enzyme activity in circulating leukocytes or cultured fibroblasts reveals profound deficiency (<10% of normal). Sequence analysis of the IDS gene establishes the underlying mutation.
• Skeletal Survey – Spine: Lateral views reveal anterior-inferior beaking of L1 and L2 vertebral bodies (hypoplasia of the anterosuperior vertebral margin), thoracolumbar kyphotic gibbus deformity, and generalized platyspondyly.
• Skeletal Survey – Cervical Spine: Open-mouth odontoid and lateral flexion-extension views identify odontoid hypoplasia, os odontoideum, and dynamic atlantoaxial instability (AADI > 3.5 mm). Cervical MRI is mandatory to evaluate retro-odontoid soft-tissue thickening, space available for the cord (SAC < 13 mm), and intramedullary T2 hyperintensity signifying compressive myelomalacia.
• Skeletal Survey – Pelvis and Hips: Bilateral flared iliac wings with shallow, dysplastic acetabula, coxa valga, and flattened, fragmented femoral heads mimicking Perthes disease.
• Skeletal Survey – Thorax: Anteroposterior chest radiograph reveals spatulate (“oar-shaped” or “paddle-shaped”) ribs characterized by narrow vertebral origins and wide, expanded anterior spatulate segments.
• Skeletal Survey – Hands and Wrists: Radiographs show short, wide tubular bones; bullet-shaped metacarpals with characteristic conical proximal pointing of the bases of the second through fifth metacarpals; and distal radial and ulnar physeal sloping facing each other (“V-shaped” deformity).
• Electrodiagnostic Studies (EMG/NCS): Nerve conduction studies of the upper extremities demonstrate delayed median distal motor latency (>4.2 ms) and prolonged or absent median sensory nerve action potentials across the wrist, with preserved ulnar nerve parameters, confirming pediatric carpal tunnel syndrome.

7. Classification

Validated classification and staging systems guide therapeutic thresholds, surgical indications, and prognostic counseling in sex-linked musculoskeletal disorders.

Arnold-Hilgartner Classification of Hemophilic Arthropathy

The Arnold-Hilgartner staging system is the primary radiographic classification for hemophilic joint disease, correlating progressive structural joint destruction with therapeutic decision-making.

World Federation of Hemophilia (WFH) Baseline Factor Severity Classification

The World Federation of Hemophilia classifies hemophilia into three distinct severity categories based on circulating endogenous clotting factor levels.

Functional Staging Scales in Duchenne Muscular Dystrophy: Vignos and Brooke

The Vignos Lower Extremity Scale and Brooke Upper Extremity Scale track progressive functional motor decline and define critical timing thresholds for orthopaedic interventions.

Skeletal Manifestations of Dysostosis Multiplex in Hunter Syndrome (MPS II)

Dysostosis multiplex encompasses characteristic skeletal lesions resulting from defective endochondral and periosteal ossification.

8. Treatment

Medical / Nonoperative

Medical management across sex-linked recessive conditions requires specialized pharmacological regimens to prevent target-organ breakdown and optimize patients for orthopaedic surgery.

• Hemophilia Factor Prophylaxis: Primary regular prophylaxis with recombinant or plasma-derived clotting factor concentrates represents the gold standard of care. Regimens typically administer 25 to 40 IU/kg of Factor VIII three times weekly (or every other day) for Hemophilia A, and 40 to 50 IU/kg of Factor IX twice weekly for Hemophilia B, targeting a trough activity level >1% to 3% to prevent spontaneous hemarthroses. Extended half-life (EHL) products utilize Fc-fusion, albumin-fusion, or PEGylation to extend dosing intervals.
  • Non-Factor Therapy (Emicizumab): A humanized bispecific monoclonal antibody that bridges activated Factor IX and Factor X, mimicking the cofactor function of activated Factor VIII. Administered subcutaneously (weekly, biweekly, or monthly), emicizumab has revolutionized routine bleeding prophylaxis in Hemophilia A with or without inhibitors.
  • Acute Hemarthrosis Management: Immediate factor concentrate infusion is required. For moderate bleeds, raise factor levels to 40% to 50%; for severe or life-threatening bleeds (e.g., iliopsoas hematoma), correct to 80% to 100%. Apply RICE principles (Rest, Ice, Compression, Elevation) with short-term immobilization (24 to 48 hours). Pharmacological Safety Rule: Aspirin and non-selective NSAIDs are strictly contraindicated due to platelet inhibition. Paracetamol (acetaminophen) and selective COX-2 inhibitors (e.g., celecoxib) can be used under hematological supervision.
  • Physical Therapy and Rehabilitation: Supervised physical therapy incorporating active-assisted range of motion, isometric strengthening, and balance training restores joint kinematics following acute hemarthroses. High-impact contact sports are restricted.
  • Chemical and Radioisotope Synovectomy: Indicated for persistent, recurrent target joint synovitis refractory to 6 months of optimized factor prophylaxis in Arnold-Hilgartner stages I to III. Intra-articular injection of beta-emitting radionuclides induces selective radiation necrosis and fibrosis of the hypervascular synovial pannus without damaging underlying articular cartilage. Agents include Yttrium-90 (Y-90; penetration depth 3.6 mm, ideal for the knee), Rhenium-186 (Re-186; penetration depth 1.2 mm, ideal for elbow and ankle), and Erbium-169 (penetration depth 0.3 mm, for small hand/foot joints).
• Duchenne Muscular Dystrophy Pharmacotherapy and Supportive Care:
  • Corticosteroid Therapy: Glucocorticoids represent the cornerstone of medical management in DMD. Regimens include Prednisone (0.75 mg/kg/day) or Deflazacort (0.9 mg/kg/day). Chronic glucocorticoids stabilize muscle membrane integrity, decrease inflammation, prolong independent ambulation by 2 to 3.5 years, preserve upper extremity and diaphragmatic strength, and significantly reduce the incidence of progressive scoliosis (reducing spinal fusion rates from ~36% to ~15%). Complications include weight gain, Cushingoid features, growth suppression, delayed puberty, cataract formation, and severe secondary osteoporosis predisposing to vertebral compression fractures.
  • Bone Health Maintenance: Baseline and annual Dual-energy X-ray Absorptiometry (DXA) scans, combined with lateral spine radiographs, are required. Maintain 25-hydroxyvitamin D levels >30 ng/mL with daily cholecalciferol and age-appropriate elemental calcium. Intravenous bisphosphonates (Zoledronic acid 0.05 mg/kg every 6 months or Pamidronate) are indicated for low-trauma vertebral compression fractures or clinically significant fragility fractures.
  • Orthotics and Stretching: Custom molded night-time ankle-foot orthoses (AFOs) positioned in neutral dorsiflexion delay fixed contracture of the gastrocnemius-soleus complex. Daytime passive stretching programs focus on heel cords, hamstrings, and iliotibial bands. Daytime use of rigid AFOs during walking is contraindicated because eliminating compensatory plantarflexion precipitates knee buckling in boys with quadriceps weakness.
• Hunter Syndrome Medical Management:
  • Enzyme Replacement Therapy (ERT): Intravenous Idursulfase (recombinant human iduronate-2-sulfatase) administered at 0.5 mg/kg once weekly. Idursulfase clears lysosomal GAG storage in viscera, reducing hepatosplenomegaly, improving joint range of motion, and enhancing forced vital capacity and 6-minute walk distance. Major Limitation: Intravenously administered idursulfase does not cross the blood-brain barrier and has minimal penetration into avascular articular cartilage, dense fibrous ligaments, and bone. Consequently, ERT does not arrest cognitive decline, prevent cervical spinal cord compression, or halt dysostosis multiplex.
  • Multidisciplinary Airway Surveillance: GAG infiltration produces macroglossia, adenotonsillar hypertrophy, vocal cord thickening, tracheobronchomalacia, and restrictive thoracic disease. Polysomnography is required to guide nocturnal continuous or bilevel positive airway pressure (CPAP/BiPAP).

Operative

Operative intervention requires exact procedural execution, specialized hematological or anesthetic protocols, and disease-specific instrumentation strategies.

Operative Principles in Hemophilia

• Surgical Hemostasis and Factor Replacement Protocols: Major elective orthopaedic surgery (TKA, THA, pseudotumor resection, open synovectomy) requires a preoperative peak factor activity of 100% (1.0 IU/mL) achieved 30 to 60 minutes before skin incision. For Factor VIII, Units required = Body Weight (kg) × Desired Factor VIII Increase (%) × 0.5. For Factor IX, Units required = Body Weight (kg) × Desired Factor IX Increase (%) × 1.0 (plasma-derived) or 1.2 to 1.4 (recombinant FIX due to larger volume of distribution). Maintain factor levels >50% to 70% continuously for days 1 to 5, >50% for days 6 to 10, and >30% until complete wound healing and suture removal (days 14 to 21). Factor replacement is administered via continuous intravenous infusion or intermittent boluses every 8 to 12 hours (FVIII) or 12 to 24 hours (FIX). In patients with high-titer inhibitors (≥5 BU), bypassing agents such as recombinant activated Factor VII (rFVIIa; 90 to 120 mcg/kg every 2 hours) or activated prothrombin complex concentrate (aPCC/FEIBA; 50 to 100 U/kg every 8 to 12 hours) are required.
• Total Knee Arthroplasty (TKA) in Hemophilic Arthropathy: Indicated for end-stage Arnold-Hilgartner Stage IV to V arthropathy with severe pain and functional limitation. Perform an extensive synovectomy to remove friable hypervascular tissue and reduce postoperative hemarthrosis. Correct fixed flexion contractures through posterior capsular release, resection of posterior femoral osteophytes, and distal femoral recutting. Collateral ligament contractures and bone loss frequently necessitate semi-constrained (constrained condylar knee [CCK]) or rotating-hinge implants rather than posterior-stabilized designs. Cemented fixation with antibiotic-impregnated polymethylmethacrylate is standard. Ensure meticulous electrocautery hemostasis before tourniquet deflation. Closed suction drainage is utilized to prevent tense hematoma formation under factor coverage.
• Management of Hemophilic Pseudotumors: Needle aspiration or incisional biopsy is strictly contraindicated due to catastrophic hemorrhage and sinus tract infection. Treatment requires complete en bloc surgical excision under high-dose continuous factor replacement. Preoperative superselective transcatheter arterial embolization performed 24 to 48 hours prior to surgery devascularizes the lesion, reducing intraoperative blood loss. In large pelvic or proximal femoral lesions, structural allograft reconstruction, cage reconstruction, or modular oncology megaprostheses are required to span massive osseous defects.

Operative Principles in Duchenne Muscular Dystrophy

• Anesthetic Protocol and Safety: Absolute contraindication to succinylcholine and volatile inhalational anesthetics (halothane, isoflurane, sevoflurane, desflurane). Anesthesia must be maintained strictly with Total Intravenous Anesthesia (TIVA), utilizing propofol, remifentanil or fentanyl, and non-depolarizing neuromuscular blocking agents (e.g., rocuronium, vecuronium) if required, with reversal via sugammadex. Prepare active cooling blankets, intravenous dantrolene, and calcium chloride in the operating suite.
• Posterior Spinal Instrumentation and Fusion (PSF): The primary goal is to arrest collapsing neuromuscular scoliosis, eliminate painful pelvic-rib impingement, maintain a level sitting foundation, and slow the decline of pulmonary function.
  • Instrumentation Strategy: High-density, multi-level pedicle screw constructs using dual 5.5 mm or 6.0 mm cobalt-chromium or titanium rods. Subperiosteal exposure from T2 or T3 down to the sacrum/pelvis. In non-ambulatory patients with pelvic obliquity (>5 degrees) or curves >40 degrees, instrument down to the pelvis utilizing bilateral S2-alar-iliac (S2AI) screws or iliac bolts. Anterior spinal release or thoracotomy is contraindicated due to severe pulmonary morbidity.
  • Blood Loss Mitigation: Administer intravenous tranexamic acid (TXA; loading dose 30 mg/kg followed by continuous infusion of 5 to 10 mg/kg/hr) to suppress hyperfibrinolysis. Utilize intraoperative cell salvage and bipolar electrocautery.
  • Neuromonitoring: Maintain continuous multimodal intraoperative neuromonitoring with somatosensory-evoked potentials (SSEPs) and motor-evoked potentials (MEPs).
• Lower Extremity Contracture Releases: In selected ambulatory boys losing mobility due to equinovarus foot deformities, percutaneous or open Achilles tendon lengthening (TAL), split anterior tibial tendon transfer (SPLATT) to the cuboid or lateral cuneiform, and plantar fasciotomy can restore a plantigrade foot. Tenotomies of the tensor fasciae latae and hip flexors can be added. Caveat: Postoperative immobilization must be minimized (weight-bearing casting within 48 hours) to prevent rapid disuse atrophy and permanent loss of ambulation.

Operative Principles in Hunter Syndrome (MPS II)

• Extended Open Carpal Tunnel Release: First-line surgical priority. Endoscopic carpal tunnel release is contraindicated due to altered anatomical landmarks and dense GAG infiltration. Perform an extended open incision curving across the wrist flexion crease. Completely transect the thickened transverse carpal ligament, visualize and protect the recurrent motor branch of the median nerve, and perform a radical tenosynovectomy of the hypertrophic flexor tenosynovium. Neurolysis of the median nerve epineurium is performed if severe constriction is present.
• Craniocervical Decompression and Instrumented Fusion: Indicated for progressive cervical myelopathy, space available for the cord <13 mm, or atlantoaxial instability (AADI > 3.5 mm). Surgical intervention comprises posterior laminectomy of C1, foramen magnum decompression, and rigid instrumented posterior occipitocervical (Occiput to C2/C3) or atlantoaxial (C1 lateral mass to C2 pedicle/pars) screw-rod fixation supplemented with autogenous bone grafting. Fiberoptic awake or video-assisted endotracheal intubation in strict neutral cervical alignment is mandatory to avoid hyperextension-induced cord transection.

Indications & Contraindications

Exact clinical and numerical thresholds govern surgical candidacy:

• Hemophilia Total Joint Arthroplasty: Indicated in Arnold-Hilgartner Stage IV or V arthropathy with refractory pain, structural joint destruction, and failure of conservative factor prophylaxis. Absolute Contraindication: Uncontrolled high-titer inhibitor without bypassing agent availability; active untreated joint or systemic infection.
• DMD Posterior Spinal Fusion: Indicated when the scoliosis Cobb angle reaches 20 to 30 degrees in a non-ambulatory boy, especially when progressing >10 degrees per year, while Forced Vital Capacity (FVC) remains >30% to 50% of predicted values and Left Ventricular Ejection Fraction (LVEF) is >35%. Relative / Absolute Contraindications: Severe pulmonary impairment with FVC <20% to 25% unresponsive to nocturnal non-invasive ventilation; uncompensated dilated cardiomyopathy with LVEF <25% to 30% representing prohibitive operative mortality.
• Hunter Syndrome Carpal Tunnel Release: Indicated immediately upon electrophysiological confirmation of median neuropathy (distal motor latency >4.2 ms) or clinical clawing, regardless of whether the young child verbalizes symptoms.
• Hunter Syndrome Cervical Stabilization: Indicated for dynamic atlantoaxial instability (AADI > 3.5 mm), canal stenosis with SAC <13 mm, or MRI evidence of cord compression / T2 signal hyperintensity.

9. Outcome

Modern multidisciplinary protocols have substantially enhanced functional outcomes, implant survivorship, and life expectancy across sex-linked musculoskeletal disorders.

• Hemophilic Arthroplasty Survivorship: Total knee arthroplasty in hemophilia provides significant pain relief and functional restoration, with mean Knee Society Scores improving from <35 preoperatively to >80 postoperatively. However, 10-year implant survivorship in hemophilia ranges between 85% and 90%, which is lower than in non-hemophilic osteoarthritis populations. Aseptic loosening and late periprosthetic infection are the primary failure modes. Total hip arthroplasty achieves comparable pain relief with 10-year implant survivorship of approximately 88% to 92%. Radioisotope synovectomy achieves a 75% to 80% reduction in annual bleeding frequency in Arnold-Hilgartner stages I to III, preserving joint integrity when applied early.
• Spine Deformity Correction in DMD: Posterior spinal fusion utilizing modern multi-level pedicle screw constructs achieves solid arthrodesis in >95% of patients and halts progressive spinal collapse. Surgery corrects curve magnitude by 60% to 70%, stabilizes pelvic obliquity to <5 degrees, restores level wheelchair sitting, and eliminates painful costopelvic impingement. Although spinal fusion does not reverse underlying diaphragmatic muscle degeneration, stabilizing the thoracic cage prevents rapid secondary restrictive thoracic volume loss, preserving sitting pulmonary capacity compared to untreated historic controls.
• Corticosteroid Efficacy in DMD: Long-term comparative registry analyses demonstrate that chronic corticosteroid therapy delays the loss of independent ambulation by an average of 2 to 3.5 years, reduces the lifetime rate of scoliosis surgery from 36.8% to 15.6%, and delays the age at spinal fusion by an average of 2.3 years. Overall median life expectancy has extended from 19 years in untreated cohorts to 28 to 32 years with combined pharmacotherapy, spinal stabilization, and ventilatory support.
• Carpal Tunnel and Cervical Decompression in Hunter Syndrome: Early open carpal tunnel release halts progressive median nerve axonotmesis, with over 85% of pediatric patients showing recovery or stabilization of thenar muscle bulk and restoration of active thumb opposition. However, recurrent compression occurs in 10% to 20% of cases within 5 to 7 years due to ongoing lysosomal GAG accumulation, necessitating long-term surveillance. Rigid posterior occipitocervical decompression and fusion achieves bony union in >85% of cases, arresting spastic quadriparesis and eliminating the risk of sudden death from craniocervical instability.

10. Complications

Complications in sex-linked musculoskeletal disorders span life-threatening anesthetic crises, catastrophic hemorrhage, inhibitor development, and hardware failure, requiring vigilant perioperative protocols.

11. Pearls and Pitfalls

• Pearl: Preoperative Bethesda Assay Timing: In hemophilia, always verify a negative inhibitor screen (Bethesda assay <0.5 BU) within 2 to 4 weeks prior to elective surgery. Repeat the assay immediately prior to skin incision. An undetected low-titer inhibitor will manifest as catastrophic, uncontrollable intraoperative bleeding once exogenous factor is infused and cleared by circulating antibodies.
• Pearl: Confirm Factor Recovery In Vivo: Do not rely exclusively on theoretical factor dosing calculations. Infuse the calculated factor replacement dose 30 to 60 minutes prior to surgery and draw a peak factor activity level 15 to 30 minutes post-infusion to confirm that a true 100% circulating activity has been established before making the skin incision.
• Pearl: Pelvic Fixation Mandate in DMD Spinal Fusion: In non-ambulatory DMD boys, always instrument down to the pelvis utilizing bilateral S2-alar-iliac (S2AI) screws. Terminating the fusion construct at L5 in a patient with progressive neuromuscular weakness almost universally results in subsequent severe pelvic obliquity (>15 degrees), sitting imbalance, and rib-pelvis impingement, necessitating complex revision surgery in a patient with compromised cardiopulmonary reserves.
• Pearl: Early Carpal Tunnel Release in MPS II: In Hunter syndrome, maintain a zero-threshold policy for bilateral open carpal tunnel release in toddlers upon electrodiagnostic confirmation of median neuropathy. Do not wait for the child to complain of numbness or tingling; compression is insidious and will result in irreversible thenar motor axonotmesis.
• Pearl: Rigid Neutral Cervical Alignment in MPS II: Mandate video-laryngoscopy or awake fiberoptic intubation in all patients with Hunter syndrome, keeping the cervical spine strictly in neutral alignment. Avoid any passive hyperextension during laryngoscopy, as odontoid hypoplasia and retro-odontoid pannus predispose to acute atlantoaxial subluxation and fatal cervicomedullary transection.
• Pitfall: Biopsying a Hemophilic Pseudotumor: Mistaking an expanding, osteolytic hemophilic pseudotumor of the pelvis or femur for an osteosarcoma or soft-tissue sarcoma and performing a percutaneous needle or open biopsy is catastrophic. Biopsy triggers uncontrollable hemorrhage, cutaneous fistula formation, infection, and potential amputation or death. Always check coagulation profiles and obtain multiplanar MRI with gradient-echo sequences before biopsying an aggressive osseous lesion in a male child.
• Pitfall: Administering Depolarizing Muscle Relaxants in DMD: Administering succinylcholine or volatile inhalational anesthetics to a patient with DMD or BMD induces acute, life-threatening rhabdomyolysis and hyperkalemic cardiac arrest. Maintain strict vigilance and communication with the pediatric neuroanesthesia team to enforce Total Intravenous Anesthesia (TIVA).
• Pitfall: Delayed Spinal Fusion in DMD: Delaying posterior spinal fusion until the scoliosis curve exceeds 40 to 50 degrees or until Forced Vital Capacity falls below 30% of predicted values sharply escalates perioperative morbidity and mortality. Surgery must be scheduled when the curve reaches 20 to 30 degrees while pulmonary and cardiac reserves are preserved.
• Pitfall: Premature Tapering of Clotting Factor: Discontinuing or abruptly tapering factor replacement on postoperative days 3 to 5 following total joint arthroplasty in hemophilia frequently results in massive delayed intra-articular hemorrhage at days 7 to 10. Factor levels must be maintained >50% through day 10 and >30% through days 14 to 21 to cover aggressive rehabilitation.
• Pitfall: Endoscopic Carpal Tunnel Release in Hunter Syndrome: Attempting endoscopic carpal tunnel release in a child with MPS II is a critical error. The severe fibrous thickening of the transverse carpal ligament, hypertrophic flexor tenosynovium, and distorted median nerve anatomy preclude safe visualization and carry a high risk of iatrogenic nerve transection. Extended open release is mandatory.

12. Controversy

Several clinical and surgical controversies persist regarding optimal management strategies in sex-linked musculoskeletal conditions:

1. Distal Fusion Level in DMD Neuromuscular Scoliosis: L5 versus Pelvis

A longstanding debate in pediatric spine deformity surgery concerns the distal extent of fusion in Duchenne muscular dystrophy. Historical protocols advocated stopping posterior instrumentation at L5 in non-ambulatory patients who had minimal or no pelvic obliquity (<5 degrees) and curves <40 degrees. Proponents emphasized reduced operative duration, less intraoperative blood loss, preservation of residual lumbosacral motion, and avoidance of complex pelvic screw placement in osteopenic ilia.

However, modern evidence and contemporary spine deformity consensus strongly favor routine extension of fusion to the pelvis using bilateral S2AI screws for all non-ambulatory boys. Studies demonstrate that stopping at L5 leads to late pelvic obliquity decompensation (>15 degrees) in 20% to 40% of patients as paraspinal muscle atrophy progresses, resulting in seated balance collapse and skin breakdown over the ischium. Revision surgery to the pelvis carries severe risks because pulmonary function and cardiac performance deteriorate inexorably over time. Consequently, primary pelvic fixation is now considered the standard of care for non-ambulatory DMD spinal deformity.

2. Perioperative Management of Emicizumab in Major Orthopaedic Surgery

The widespread adoption of emicizumab for Hemophilia A prophylaxis has introduced clinical complexity in the surgical setting. While emicizumab provides outstanding protection against spontaneous daily bleeding, steady-state therapeutic levels are insufficient to provide complete hemostasis during major orthopaedic procedures such as total knee arthroplasty, osteotomy, or pseudotumor resection. Supplemental Factor VIII concentrate must be co-administered to achieve the standard target peak level of 100%.

The controversy intensifies in patients with high-titer Factor VIII inhibitors who require surgery while receiving emicizumab. Co-administration of activated prothrombin complex concentrate (aPCC/FEIBA) with emicizumab carries a critical black-box warning for thrombotic microangiopathy (TMA) and severe venous thromboembolism. In this cohort, recombinant activated Factor VII (rFVIIa) must be utilized as the bypassing agent, administered at lower initial doses (45 to 90 mcg/kg) with rigorous laboratory monitoring to balance hemostasis against systemic thrombosis.

3. Radioisotope versus Arthroscopic Synovectomy in Hemophilic Arthropathy

Debate continues regarding the optimal primary synovectomy technique for recurrent hemophilic target joints refractory to medical prophylaxis (Arnold-Hilgartner stages I to III). Proponents of radioisotope synovectomy (Y-90, Re-186) highlight that it is an outpatient, minimally invasive injection requiring only 1 to 2 doses of clotting factor coverage, eliminating surgical wound complications and hospital admissions. However, radioisotope synovectomy does not allow mechanical debridement of impinged osteophytes, loose bodies, or thickened fibrous plicae, and repeat injections are required in 20% to 25% of cases.

Conversely, arthroscopic synovectomy allows direct intra-articular visualization, comprehensive mechanical excision of the hypertrophic pannus, capsular release, and debridement of chondral flaps. Nevertheless, arthroscopic synovectomy requires continuous high-dose factor concentrate coverage for 10 to 14 days, markedly elevating treatment costs, and carries risks of postoperative arthrofibrosis, deep hemarthrosis, and portal sinus tracts.

4. Lower Extremity Tendon Releases to Prolong Ambulation in DMD

Historical protocols advocated multi-level soft-tissue tendon surgery (percutaneous Achilles tendon lengthening, posterior tibial tendon transfer, iliotibial band release) combined with long-leg bracing (KAFOs) to prolong ambulation by 1 to 2 years in boys approaching wheelchair dependence. Proponents argued that prolonging upright standing delayed contractures, enhanced quality of life, and deferred spinal deformity.

In the modern era of chronic corticosteroid therapy, this approach has largely fallen out of favor. Corticosteroids independently prolong ambulation without surgical intervention. Critics emphasize that any postoperative casting, immobilization, and bed rest accelerate disuse muscle atrophy, causing rapid loss of marginal quadriceps strength and permanently ending independent ambulation. Current consensus restricts lower extremity releases to motivated patients with preserved quadriceps strength (>grade 3/5) who can undergo immediate postoperative weight-bearing.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Srivastava A, Santagostino E, Dougall A et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020. doi:10.1111/hae.14046 [Level IV: Clinical Case Series / Cohort Study]
• Birnkrant DJ, Bushby K, Bann CM et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018. doi:10.1016/S1474-4422(18)30025-5 [Level IV: Clinical Case Series / Cohort Study]
• Elshennawy S, Zahreldin AA, Mortada H et al. The Efficacy of Physical Therapy Modalities in Patients With Hemophilia: A Systematic Review of Randomized Controlled Trials With Meta-analysis. Arch Phys Med Rehabil. 2023. doi:10.1016/j.apmr.2022.05.023 [Level I: Systematic Review / Meta-Analysis]
• Raudenbush BL, Thirukumaran CP, Li Y et al. Impact of a Comparative Study on the Management of Scoliosis in Duchenne Muscular Dystrophy: Are Corticosteroids Decreasing the Rate of Scoliosis Surgery in the United States?. Spine (Phila Pa 1976). 2016. doi:10.1097/BRS.0000000000001534 [Level II: Comparative Study / Decision Analysis]
• Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011. doi:10.1093/rheumatology/ker394 [Level IV: Clinical Case Series / Cohort Study]

15. Master Class Pro-Tip

In hemophilic total joint arthroplasty, intraoperative factor correction is only half the battle. The most dangerous postoperative window occurs between days 7 and 10, when fibrinolytic activity in the healing joint peaks just as factor replacement is prematurely stepped down. Maintain trough factor activity strictly above 50% through day 10 and above 30% through day 21, and never allow rapid, forced passive manipulation under anesthesia for postoperative stiffness. For patients with Duchenne muscular dystrophy undergoing posterior spinal fusion, the definitive technical pearl is twofold: always achieve rigid pelvic fixation using S2-alar-iliac screws to avoid late pelvic obliquity decompensation, and coordinate with pediatric anesthesia to mandate a strict total intravenous anesthesia (TIVA) protocol, eliminating succinylcholine and volatile inhalational agents to prevent catastrophic hyperkalemic cardiac arrest.

Master Class Surgical Pearl: Sex-Linked Recessive Musculoskeletal Disorders